Back to Ingredient Dictionary

Common Name(s): Vialox,palmitoyl dipeptide-5

CAS Number: N/a

DESCRIPTION

What It Does: Modulates nicotinic acetylcholine receptors at neuromuscular junction to reduce repetitive muscle contractions causing expression wrinkles.

Why It's Used: Neuromodulator peptide for expression line reduction via nachr antagonism, complementary to snare-inhibiting peptides like argireline.

How It Works: Diaminohydroxybutyrate moiety provides nachr binding affinity. competitive antagonism at nicotinic receptors reduces depolarization frequency and expression muscle contraction intensity.

Typically Found In: Expression line treatments,anti-wrinkle serums

TECHNICAL DETAILS

Primary Category: Active ingredient โ€“ skin restructuring peptide

Secondary Functions: Nachr modulation,expression line reduction

Application Areas:

Facial Skincare

Body Care

Hair Care

Beard Care

Color Cosmetics (Makeup)

Dietary/Oral Supplements

Typical Concentration Range: 100โ€“1000 ppm

SOURCING & ETHICS

Vegan Status: Conditional - supplier confirmation required

Halal Status: Unverified - supplier confirmation required

Source Notes: Spps synthesis. commercially available as vialox (pentapharm/dsm). [audit 2026-07-29 rev2: the record's own source_notes does not assert a non-animal origin, or instructs the reader to verify with the supplier; "yes" asserts knowledge the record does not hold. determination requires shariah-panel sign-off.]

SKIN COMPATIBILITY

Irritancy Rating: 1/5 โ€“ very low

Comedogenicity Rating: 0/5 โ€“ non-comedogenic

Sensitivity Concerns: Non-irritating; suitable for all skin types.

Safe for Sensitive Skin: Yes

SAFETY & COMPATIBILITY

Safety Profile: Exceptional safety profile. ewg score: 1.

Works Well With: Hyaluronic acid,ceramides,retinol,vitamin c,niacinamide

Avoid Combining With: Avoid mixing with high-concentration ahas at same ph (may hydrolyze peptide bonds)

SCIENTIFIC NOTE

Vialox's nachr antagonism mechanism is analogous to syn-ake, providing the same complementarity with snare-inhibiting peptides for synergistic expression line reduction through multiple inhibitory mechanisms.

Last Verified: 2026-03-12

Primary Sources: Cosing database,dsm vialox technical data